Can subcutaneous treprostinil be an alternative for treating pulmonary hypertension in patients with systemic sclerosis-related interstitial lung disease?

Subjects

Subjects :

BRAIN natriuretic factor
INTERSTITIAL lung diseases
IDIOPATHIC interstitial pneumonias
SYSTEMIC scleroderma
PULMONARY arterial hypertension
PULMONARY hypertension treatment
PULMONARY hypertension
RAYNAUD'S disease
HEART failure

Details

Language :

English

ISSN :

27954552

Volume :

3

Issue :

2

Database :

Supplemental Index

Journal :

ARP Rheumatology

Publication Type :

Academic Journal

Accession number :

178321911

Full Text :

https://doi.org/10.63032/BBMB6759